Propanc Health (PPCH) 0.0800 $PPCH Propanc Identifies

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2015 at 11:15 AM

Propanc Health (PPCH) 0.0800 $PPCH

Propanc Identifies Positive Signals for Efficacy from Pilot Animal Studies
ACCESSWIRE - Thu Jul 09, 8:46AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 9, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that positive signals have emerged in several pilot animal studies measuring the effects of PRP against several tumor types.

Propanc Enters into Research Agreement with Adaptive Biotechnologies
ACCESSWIRE - Mon Jul 06, 11:40AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 6, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that it has entered into a biomarker discovery agreement with Adaptive Biotechnologies, Seattle, WA, USA.

The Wealthy Biotech Trader's New Feature Pick Runs Over 150% After Announcement - Traders are Calling it the Next PPCH 3,200%+ Runner
ACCESSWIRE - Thu Jun 25, 10:42AM CDT
WINDSOR, ON / ACCESSWIRE / June 25, 2015 / The Wealthy Biotech Trader (or "WBT"

, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the recent move PositiveID (OTC: PSID) has made in the market. WBT reiterates PositiveID (OTC: PSID) as their pick for the summer and into the fall.
ADXS: 18.58 (+0.34)

Penny Stocks Alerts for TOTALLY HEMP CRAZY, TapImmune, Root9b Technologies, EKSO BIONICS HOLDING, Propanc Health Group, and Dominovas Energy
PR Newswire - Thu Jun 25, 7:49AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TOTALLY HEMP CRAZY (OTCMKTS:THCZ), TapImmune (OTCMKTS:TPIV), Root9b Technologies (OTCMKTS:RTNB), EKSO BIONICS HOLDING (OTCBB:EKSO), Propanc Health Group (OTCMKTS

PCH), and Dominovas Energy (OTCMKTS

NRG).

Propanc Provides Shareholder Update
ACCESSWIRE - Fri Jun 19, 7:52AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 19, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced a summary of Corporate and R&D activities currently underway as part of a shareholder update since presenting at the SeeThru Equity Conference last month.

Penny Stocks Recap for Propanc Health Group, Arrayit Corp, PositiveID, TapImmune, TOTALLY HEMP CRAZY, and Medican Enterprises
PR Newswire - Fri Jun 19, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Propanc Health Group (OTCMKTS

PCH), Arrayit Corp (OTCMKTS:ARYC), PositiveID (OTCMKTS

SID), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), and Medican Enterprises (OTCMKTS:MDCN).

Propanc Settles Two Outstanding Convertible Debts
ACCESSWIRE - Thu Jun 18, 7:31AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 18, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company repaid two outstanding convertible notes as part of its plans to reduce overall debt.

Three Companies with the Ingredients to Follow in the Footsteps of Advaxis (NASDAQ: ADXS)
ACCESSWIRE - Tue Jun 16, 2:34PM CDT
WINDSOR, ON / ACCESSWIRE / June 16, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the seldom huge potential of the OTC market when used as a proper stepping-stone to a national stock exchange.
ADXS: 18.58 (+0.34)

Penny Stocks Research for Hangover Joe's, Terra Tech, TOTALLY HEMP CRAZY, Medican Enterprises, Propanc Health Group, and MaryJane Group
PR Newswire - Thu Jun 11, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Hangover Joe's (OTCMKTS:HJOE), Terra Tech (OTCMKTS:TRTC), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), Medican Enterprises (OTCMKTS:MDCN), Propanc Health Group (OTCMKTS

PCH), and MaryJane Group (OTCMKTS:MJMJ).

Propanc Briefs Investors at the SeeThruEquity 4th Annual Investor Conference
ACCESSWIRE - Fri May 29, 10:47AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 29, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company briefed investors at the SeeThruEquity 4th Annual Microcap Investor Conference, held at the Convene Grand Central, Midtown Manhattan, New York, on Thursday, May 28th.

SeeThruEquity Initiates Coverage on Propanc Health Group with a Price Target of $1.52
ACCESSWIRE - Wed May 27, 9:12AM CDT
NEW YORK, NY / ACCESSWIRE / May 27, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Propanc Health Group Corp.. (PINKSHEETS: PPCH) with a Price Target of $1.52.

Corrected Article - The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
ACCESSWIRE - Tue May 19, 4:00PM CDT
WINDSOR, ON / ACCESSWIRE / May 19, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
VSTM: 7.36 (+0.24), CERU: 4.52 (+0.12), PPHM: 1.29 (+0.06)

The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
ACCESSWIRE - Sun May 17, 2:43PM CDT
WINDSOR, ON / ACCESSWIRE / May 17, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
VSTM: 7.36 (+0.24), CERU: 4.52 (+0.12), PPHM: 1.29 (+0.06)

Propanc Engages Maxim Group LLC as Strategic Advisors
ACCESSWIRE - Wed May 13, 5:01AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 13, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, announced today that it has retained Maxim Group LLC, a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting Propanc in its strategies for maximizing shareholder value through its full scope of investment banking services, including pursuing a listing of the Company's common stock on a nationally recognized exchange.

Propanc to Study Effects of PRP on Cancer Stem Cells
ACCESSWIRE - Tue May 12, 9:42AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 12, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that the Company will be investigating the effects of PRP against cancer stems cells with its joint research partner at the University of Jaen, Spain.

PROPANC SETTLES OUTSTANDING CONVERTIBLE DEBTS
ACCESSWIRE - Thu May 07, 11:37AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 7, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company repaid two outstanding convertible notes as part of its plans to repay loans due for conversion and reduce overall debt.

Are These in Your Portfolio? 4 Trending Companies (GALE, AEZS, PPCH, THLD)
ACCESSWIRE - Wed May 06, 7:30AM CDT
WINDSOR, ON / ACCESSWIRE / May 6, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing little-known Biotech stocks, would like to highlight several oncology (or cancer) focused biotech stocks providing investors with greatest opportunity for significant growth potential.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Royce Global Trust: Insights on RGT's Performance

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Palmdale Propane Expands with Affordable Gas Buy

Propane Power Play in Florida's Market Here's a little tune you don't hear every day: two local businesses tangoing to the beat of expansion without making a public peep about the price. Palmdale Propane, a powerhouse under the Palmdale Oil umbrella, just snapped up Affordable Gas, a local player from Belle Glade, Florida. This acquisition strengthens its grip on the...

Nelson Peltz Doubles Down: Burgers or Pucks?

Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...

South Dakota's BEES Launch: Child Care Assistance Goes Live

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Veterinary Implants Market to Hit $0.98B by 2031

Veterinary Implants Market: A Growth Tale Something's stirring in the veterinary world, my friend. The Veterinary Implants Devices Market is hitting some serious strides, and we're looking at a valuation touching nearly $0.98 billion by 2031. If you're eyeing the veterinary sector, it's time to sharpen those pencils and take notes on where the trend winds are blowing....

Proton Therapy: A Game-changer in Breast Cancer Treatment

Understanding the Radiation Conundrum When it comes to breast cancer, there's no sugarcoating it—the diagnosis alone can shake the foundation of anyone's life. But once the dust settles, another layer of decisions begins. One of the trickiest questions patients face is, "What radiation options are out there?" That's where proton therapy comes in, and it's high time we...

Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Markel Stays the Course: Solid Q3 Results in 2026

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...